on a number of factors.
Ratings & Metrics
|Entity||Document Type||Tax ID|
|National Jewish Health & Subsidiary||Consolidated Audited Financial Statements||Multiple|
|National Jewish Health||IRS Form 990||74-2044647|
Entity: National Jewish Health & Subsidiary
Document Type: Consolidated Audited Financial Statements
Tax ID: Multiple
Entity: National Jewish Health
Document Type: IRS Form 990
Tax ID: 74-2044647
Governance & Transparency
|1||Michael Salem, M.D.||President/CEO||$1,648,461|
|2||Greg Downey, M.D.||Executive VP, Academic Affairs||$840,183|
|3||Richard Martin, M.D.||Chairman, Dept of Medicine||$571,052|
Name: Michael Salem, M.D.
Name: Greg Downey, M.D.
Title: Executive VP, Academic Affairs
Name: Richard Martin, M.D.
Title: Chairman, Dept of Medicine
According to the National Jewish Health consolidated audit of June 30, 2019 (Note 1(a), Corporate Organization, Organization re: Joint Ventures):
"Effective December 2013, National Jewish Health formed a limited liability corporation in a joint venture with Icahn School of Medicine doing business as the Mount Sinai – National Jewish Respiratory Institute to oversee the creation and operations of a joint respiratory institute at various sites in the Mount Sinai integrated health care system in New York City, New York.
"Effective August 2014, National Jewish Health entered into a joint operating agreement with Sisters of Charity of Leavenworth (SCL) Health/St. Joseph Hospital for the joint management and operation of National Jewish Health's in-state patient care and St. Joseph Hospital. The new entity is overseen by a Board of Directors with representation from both entities.
"Effective April 2017, National Jewish Health formed a limited liability corporation in a joint venture with Thomas Jefferson University doing business as the Jane and Leonard Korman Jefferson Health / National Jewish Health Respiratory Institute to oversee the development and operations of a joint respiratory institute at various sites in the Jefferson Health System in Philadelphia, Pennsylvania."
According to the National Jewish Health consolidated audit of June 30, 2019 (Note 21, Related-party Transactions):
"National Jewish Health from time-to-time in the normal course of business and within the guidelines of its conflict of interest policy, has entered into transactions with companies for which certain members of the companies' management also serve on the board of National Jewish Health. Management believes prices paid by National Jewish Health have been equal to or less than the prices that would have been paid in transactions with parties not related to National Jewish Health."
According to the National Jewish Health (NJH) tax filing for the fiscal year ended June 30, 2019, NJH reports for Business Transactions Involving Interested Persons (IRS Form 990 Schedule L, Part IV):
(1) A transaction in the amount of $621,091 involving Mariner Kemper, former Board Member. The transaction is described as: "Banking Services and LOC Fees."
(2) A transaction in the amount of $152,388 involving Lisa Cicutto, spouse of EVP of Academic Affairs. The transaction is described as: "Salary."
According to the National Jewish Health tax filing for the fiscal year ended June 30, 2019, NJH reports receiving contributions of non-cash items on which it placed a value of $437,000 (IRS Form 990, Schedule M).
[Note: CharityWatch generally excludes the value of in-kind (non-cash) donations of goods and services from its calculations of Program % and Cost to Raise $100. More information on how grades are calculated and the treatment of in-kind donations can be found on the Our Process page.]
According to the National Jewish Health consolidated audit of June 30, 2019 (Note 13, Construction in Progress) [$s in thousands, as noted]:
"At June 30, 2019, National Jewish Health had several on-going construction projects. The total projected costs related to these projects are estimated at $2,226 [thousand]. As of June 30, 2019, National Jewish Health has expended $437 [thousand] related to these projects."
According to the National Jewish Health consolidated audit of June 30, 2019 (Note 16(b), Commitments and Contingencies, Professional Liability) [$s in thousands, as noted]:
"Reserves for professional liability claims were $797 [thousand] and $815 [thousand] at June 30, 2019 and 2018, respectively. For claims covered by insurance, National Jewish Health recorded an additional $553 [thousand] and $492 [thousand] of professional liability reserves and an equal amount of insurance coverage receivables at June 30, 2019 and 2018, respectively.
"...The provision for losses related to professional liability risks is presented net of expected insurance recoveries in the [audited] consolidated statements of activities and was $88 [thousand] and ($33) [thousand] for 2019 and 2018, respectively."
According to the National Jewish Health (NJH) tax filing for the fiscal year ended June 30, 2109, NJH includes in its reporting for Compensation Information re: Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees, "Bonus & incentive compensation" paid to nine individuals in calendar year 2018, including the following (IRS Form 990, Schedule J, Part II):
(1) Michael Salem MD, President & CEO: $600,000, with reported total compensation of $1,648,461.
(2) Greg Downey MD, EVP Academic Affairs: $182,500, with reported total compensation of $840,183.
(3) Christine K. Forkner, EVP & CFO, Ass't Treasurer: $117,258, with reported total compensation of $545,811.
(4) Richard Martin MD, Chairman, Department of Medicine: $108,150, with reported total compensation of $571,052.